Five Bedsonia (Chlamydia) isolates from lymphogranuloma venereum (LGV) patients were tested for inclusion type, sulfonamide sensitivity, and mouse virulence. Two matched the classical description of LGV agents. Two were not virulent for mice by the intracerebral route, therefore fitting the description for trachoma-inclusion conjunctivitis agents. One was highly virulent for mice and sulfonamideresistant, and produced inclusions that did not stain with iodine, all characteristics generally associated with avian bedsoniae. A sixth isolate could not be adequately tested due to poor infective yields. Because of this variety of properties within the Bedsonia group, the term LGV might more appropriately be reserved for clinical disease rather than to describe a particular bedsonial agent.
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A member of the Bedsonia (Chlamydia) group of microorganisms is the causative agent of the venereal disease lymphogranuloma venereum (LGV; 2). The seventh edition of Bergey's Manual of Determinative Bacteriology refers to the agent as Miyagawanella lymphogranulomatosis and describes it as sensitive to sulfonamides, not productive of an iodine-staining inclusion, and virulent for mice when inoculated by the intracerebral (IC) and intranasal (IN) routes but not by the intraperitoneal (IP) route. Many strains of LGV have been isolated (8, 9) , but few studies thereof have been reported since the mid-1940's. The only LGV strains extant have a laboratory history of approximately 30 years. In 1967 it was reported that an agent isolated from a patient with clinical LGV had the characteristics of an avian bedsonial strain (sulfa-resistant, highly virulent for mice, and nonproductive of glycogen; 6). This paper presents results of laboratory studies on some bedsonial strains isolated from clinical cases of LGV. Most patients were servicemen and seamen returning from Southeast Asia. Clinical features and results of diagnostic tests for these patients will be published elsewhere (J. Schachter et al., J. Infect. Diseases, in press).
MATERIALS AND METHODS Isolation. Agents were isolated from bubo pus by techniques described in an earlier paper (7) . Yolk sacs (YS) of embryonated hens' eggs were used, but in some instances mice were inoculated IC. Bubo pus and YS suspensions were tested for bacteriological sterility by inoculating blood-agar plates and thioglycollate medium. Specimens were processed in a unit used solely for isolation attempts. No bedsonial agents with the characteristics of these isolates were used in the laboratory.
Serology. Group complement-fixation titers were determined by the methods described by Meyer and Eddie (3) , and the presence of group antigen was demonstrated in the isolates by preparing boiled YS antigens.
Titrations. (i) Early passage isolates were prepared as a 50% YS suspension in nutrient broth; 1-ml quantities were quick-frozen and stored at -70 C. All titrations were performed on samples from the frozen pool. The egg LD5o of the pools was determined by preparing serial 10-fold dilutions of the agents in nutrient broth. Into each of ten 7-day-old eggs, 0.2 ml of a suspension was inoculated. The eggs were incubated at 35 C and candled daily. Embryos which died early (<3 days) were discarded. Deaths were recorded through the 13th day, and the LD5o was calculated by the Reed-Muench method (5).
(ii) Serial 10-fold dilutions of the YS-grown agent were used to inoculate mice by the following routes: IC, 0.025 ml; IP, 0.5 ml; and IN, 0.025 ml. The highest concentration tested was a 20% YS suspension. Mice were anesthetized with ether for IC and IN titrations. Dead animals were autopsied, and impression smears were prepared from organs affected (lung, meninges, spleen). Observation periods were 14 (IC) and 21 days (IP or IN).
Tissue culture. Monolayers of L929 and HeLa 229 cells were prepared on cover slips in Leighton tubes by planting 150,000 cells and incubating for 3 Sulfadiazine sensitivity. Isolates were titrated in ovo. The effect of sulfadiazine was measured by inoculating 0.1 ml of sterile distilled water containing 1 mg of sulfadiazine into the YS of eggs immediately after the agent was inoculated. The LD50 values with and without sulfadiazine were determined in parallel.
Isolates tested. The isolates used, the passage level tested, and the year of isolation, respectively, were as follows: 33 Another isolate, 420-L (1967), was also tested, but because of its poor growth in the YS a stable pool could not be prepared.
RESULTS
All agents used were previously isolated in the YS of embryonated hens' eggs. Isolation attempts in mice failed. Isolates were identified as Bedsonia by serial passage of characteristic elementary bodies and by demonstrating group antigen in YS. The complement-fixing antigen titers were 1:256 or higher. All isolates except 420-L were regularly lethal for eggs, and large YS pools could be prepared to perform comparative tests on the same material. Lethality was irregular for isolate 420-L, and only occasionally did all eggs in an experiment die at a 50% inoculum, so that a pool could not be prepared. ( LGV agents presumably do not) and the cytopathic effects and rapid growth seen in tissue culture with these LGV agents. A test in primates would be impractical for routine use with all bedsonial isolates derived from the human genital tract. The pathogenicity for the conjunctiva of these LGV isolates is being studied.
The original attempts at isolating LGV agents in YS resulted in at least one isolate obtained in ovo that could not be maintained in mice (8) . The mouse was the most popular indicator host in early studies of LGV. Obviously, agents not lethal for mice could not have been isolated by this method. Studies like that of Wall (9), showing the mouse superior to the egg for isolation, may have reflected the properties of the agents prevalent in a particular area at a specific time. Apparently LGV agents need not be virulent for mice; therefore, a major criterion for differentiating between LGV and TRIC agents is lost. Possibly there are no valid differences, for there may be overlap within the groups if enough isolates are tested.
LGV is a clinical entity, and the term should not be used to refer to a single type of Bedsonia. Possibly any Bedsonia may produce this clinical entity, but certainly the agents isolated from LGV patients in this study present a spectrum of qualities within the Bedsonia group.
